Article Versions Notes

Malla S, Nyinawabera A, Neupane R, Pathak R, Lee D, Abou-Dahech M, Kumari S, Sinha S, Tang Y, Ray A, et al. Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells. Cancers. 2024; 16(15):2621. https://doi.org/10.3390/cancers16152621

Malla, Saloni, Angelique Nyinawabera, Rabin Neupane, Rajiv Pathak, Donghyun Lee, Mariam Abou-Dahech, Shikha Kumari, Suman Sinha, Yuan Tang, Aniruddha Ray, and et al. 2024. "Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells" Cancers 16, no. 15: 2621. https://doi.org/10.3390/cancers16152621

Malla, S., Nyinawabera, A., Neupane, R., Pathak, R., Lee, D., Abou-Dahech, M., Kumari, S., Sinha, S., Tang, Y., Ray, A., Ashby, C. R., Jr., Yang, M. Q., Babu, R. J., & Tiwari, A. K. (2024). Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells. Cancers, 16(15), 2621. https://doi.org/10.3390/cancers16152621